SC 54684A

Known as: SC-54684A 
 

Topic mentions per year

Topic mentions per year

1995-1998
012319951998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1999
Review
1999
Two glycoprotein IIb-IIIa antagonists (xemilofiban, SC-54684A, and orbofiban, SC-57099B), which are platelet aggregation… (More)
Is this relevant?
1998
1998
BACKGROUND Inhibition of platelet aggregation by preventing the binding of fibrinogen to glycoprotein (GP) IIb/IIIa on activated… (More)
  • figure 2
  • figure 1
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1996
1996
The inhibitory effect of a novel orally active platelet membrane glycoprotein receptor complex IIb/IIIa (GP IIb/IIIa) inhibitor… (More)
Is this relevant?
1995
1995
BACKGROUND Intravenous therapy has been shown to be beneficial in the prevention of acute platelet-associated thrombotic events… (More)
Is this relevant?
1995
1995
BACKGROUND Platelet aggregation is important in thrombotic events, and platelets play a major role in the etiology of several… (More)
Is this relevant?
1995
1995
Our initial orally active fibrinogen receptor antagonist benzamidinopentanoyl (BAP) series which was discovered through… (More)
Is this relevant?